Literature DB >> 12086169

Scleroderma renal crisis and concurrent isolated pulmonary hypertension in mixed connective tissue disease and overlap syndrome: report of two cases.

G N Andersen1, J Vasko.   

Abstract

We here report on scleroderma renal crisis (SRC) appearing concurrently with isolated pulmonary hypertension (IPHT), that is, pulmonary hypertension without interstitial lung disease with fibrosis, in a patient with mixed connective tissue disease (MCTD) and in one with overlap syndrome or undifferentiated connective tissue disease (UCTD). To the best of our knowledge there are only five previous reports on SRC in MCTD and UCTD. The unexpected appearance of SRC in the setting of concomitant IPHT and limited or absent scleroderma skin changes is discussed.

Entities:  

Mesh:

Year:  2002        PMID: 12086169     DOI: 10.1007/s10067-002-8276-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  4 in total

1.  Scleroderma renal crisis in a newly diagnosed mixed connective tissue disease resulting in dialysis-dependent chronic kidney disease despite angiotensin-converting enzyme inhibition.

Authors:  Muhammad Abdul Mabood Khalil; Nadia Iftikhar; Syed Ather Hussain; Jackson Tan
Journal:  CEN Case Rep       Date:  2012-09-28

2.  Scleroderma Renal Crisis in a Case of Mixed Connective Tissue Disease Treated Successfully with Angiotensin-Converting Enzyme Inhibitors.

Authors:  Jomana Madieh; Iman Khamayseh; Alaa Hrizat; Abdurrahman Hamadah; Kamel Gharaibeh
Journal:  Case Rep Nephrol       Date:  2021-01-06

3.  Differentiating scleroderma renal crisis from other causes of thrombotic microangiopathy in a postpartum patient.

Authors:  Muaz Abudiab; Megan L Krause; Mary E Fidler; Karl A Nath; Suzanne M Norby
Journal:  Clin Nephrol       Date:  2013-10       Impact factor: 0.975

4.  Scleroderma Renal Crisis in Mixed Connective Tissue Disease With Full Renal Recovery Within 3 Months: A Case Report With Expanding Treatment Modalities to Treat Each Clinical Sign as an Independent Entity.

Authors:  Jordana Cheta; Suresh Rijhwani; Harlan Rust
Journal:  J Investig Med High Impact Case Rep       Date:  2017-10-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.